Skip to main
CL
CL logo

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 29%
Hold 29%
Sell 7%
Strong Sell 0%

Bulls say

Colgate-Palmolive has demonstrated a robust advertising strategy, with its advertising expenditure rising from 11.6% of sales in 2021 to an anticipated 13.5% in 2024, indicating an increased investment in brand visibility and consumer engagement. Additionally, the company reported growth in both price and volume from the second quarter of 2023 to the third quarter of 2024, suggesting effective demand management and pricing strategies that bolster revenue. With approximately 70% of its sales generated internationally, including a substantial contribution from emerging markets, Colgate-Palmolive is well-positioned for continued expansion and profitability in a competitive global landscape.

Bears say

Colgate-Palmolive has experienced a notable decline in gross margin, falling by 75 basis points year-over-year in the second quarter of 2025, primarily due to raw material inflation and tariffs. The company has also reported volume declines of 0.3% and 0.9% in the first and second quarters of 2025, respectively, despite achieving price growth of 3.2% and 2.9% during the same periods. Additionally, the dog food category, a significant segment for the company, has seen a decline in US measured retail channels, with a downturn of 2.8% in the third quarter of 2025 to date, marking an acceleration from previous quarters.

Colgate-Palmolive (CL) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 14 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Nov 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89.93, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89.93, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.